Introduction
To date, a physiological function for Rhamm (receptor for hyaluronan [HA]-mediated motility) has remained elusive. Analyses of animal models demonstrated instructive roles of Rhamm in tumorigenesis and infl ammatory diseases (Tolg et al., 2003; Nedvetzki et al., 2004; Zaman et al., 2005) , consistent with evidence for a role of Rhamm in motility and proliferation/apoptosis in culture (Turley et al., 2002; Adamia et al., 2005) . However, given that migration and proliferation/apoptosis are essential functions for morphogenesis and tissue homeostasis, it is surprising that genetic deletion of Rhamm does not affect embryogenesis or adult homeostasis.
Rhamm was originally isolated from subconfl uent fi broblasts in culture (Turley, 1982) and subsequently cloned from mesenchymal cells (Hardwick et al., 1992) . Antibodies prepared against a shed form of Rhamm blocked HA-stimulated fi broblast motility, suggesting that Rhamm is a cell surface protein able to transduce motogenic signaling in culture (Turley et al., 2002) . Rhamm-bound HA was detected in cancer cell lines and shown also to occur in intracellular compartments/ structures, including the cytoskeleton, nucleus, and cytoplasm (Hascall et al., 2004; Adamia et al., 2005) . These results suggest that Rhamm has both extracellular and intracellular functions. However, the role of Rhamm as a cell surface HA receptor became controversial partly because cloning of the human (Wang et al., 1996; Hofmann et al., 1998; Crainie et al., 1999) and mouse genes (Hofmann et al., 1998) revealed an absence of both a signal peptide required for export through the Golgi/ER and membrane spanning domains common to most cell surface receptors. We now know that Rhamm resembles a group of intracellular proteins that also lack these signature characteristics of classical cell surface proteins but that are nevertheless found Rhamm −/− fi broblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair R hamm (receptor for hyaluronan-mediated motility) is an hyaluronan binding protein with limited expression in normal tissues and high expression in advanced cancers. To understand its physiological functions and identify the molecular mechanisms underlying these functions, we created mice with a genetic deletion of Rhamm. We show that Rhamm −/− fi broblasts fail to resurface scratch wounds >3 mm or invade hyaluronansupplemented collagen gels in culture. We identify a requirement for Rhamm in the localization of CD44 to the cell surface, formation of CD44-ERK1,2 (extracellularregulated kinase 1,2) complexes, and activation/subcellular targeting of ERK1,2 to the cell nucleus. We also show that cell surface Rhamm, restricted to the extracellular compartment by linking recombinant protein to beads, and expression of mutant active mitogen-activated kinase kinase 1 (Mek1) are suffi cient to rescue aberrant signaling through CD44-ERK1,2 complexes in Rh −/− fi broblasts. ERK1,2 activation and fi broblast migration/differentiation is also defective during repair of Rh −/− excisional skin wounds and results in aberrant granulation tissue in vivo. These results identify Rhamm as an essential regulator of CD44-ERK1,2 fi broblast motogenic signaling required for wound repair.
at the cell surface and regulate multiple functions by transmitting signals across the cell membrane. Examples include epimorphin/ syntaxin-2 and autocrine motility factor/phosphoglucose isomerase (Radisky et al., 2003; Nickel, 2005) . However, neither the physiological functions of proteins such as Rhamm nor the mechanisms by which these proteins regulate signaling pathways are known.
We isolated cell surface Rhamm as a motogenic factor required for rapid fi broblast motility, and we and others also provided evidence for a role of both cell surface and intracellular Rhamm in G 2 M progression in culture (Turley et al., 2002; Adamia et al., 2005) . We showed that Rhamm expression is high in aggressive human fi bromatoses (desmoid) tumors (Tolg et al., 2003) and demonstrated that genetic deletion of Rhamm strongly reduced desmoid tumor initiation and invasion in a mutant adenomatous polyposis coli and β-catenin-driven mouse model of this mesenchymal tumor. Fibroproliferative processes such as aggressive fi bromatosis resemble proliferative/migratory stages of wound healing (Cheon et al., 2002) . The expression of Rhamm is modulated during wounding (Lovvorn et al., 1998) and by fi brogenic cytokines such as TGF-β (Samuel et al., 1993) . Because factors that regulate fi broblast function play dual roles in wound repair and tumorigenesis (Park et al., 2000; Bissell and Radisky, 2001) , we have assessed whether Rhamm is involved in response to injury using models of "wounds" with Rhamm −/− (Rh
) fi broblasts in vitro as well as excisional skin wounds in vivo with Rh −/− mice. We show that Rhamm loss results in defective migration in culture as a result of aberrant CD44-ERK1,2 (extracellular-regulated kinase 1,2) signaling. We also show that ERK1,2 activity is defective in early phases of skin repair in Rh −/− mice and that this defect is associated with aberrant mesenchymal cell migration and differentiation.
Results

Fibroblast migration and invasion in culture requires Rhamm and ERK1,2
We and others have previously shown that Rhamm mediates cell migration on tissue culture plastic (Turley et al., 2002) .
To determine whether Rhamm is required for fi broblast migration under more physiological settings and whether other proteins compensate for loss of Rhamm expression, the motogenic behavior of Rh −/− and wild-type (Wt) fi broblasts were compared using scratch wounds and 3D collagen gel assays, which are designed to mimic aspects of migration in vivo (Reid et al., 2004) . Signifi cantly fewer Rh −/− than Wt fi broblasts migrated across 3-mm scratch wounds in culture (Fig. 1 A) . Time lapse of wounds revealed that motility speed of Rh −/− fi broblasts was less than Wt ( Fig. 1 A) . To confi rm that Rhamm expression is suffi cient to restore migration to Wt levels, we expressed fulllength Rhamm (Rh FL ) cDNA in Rh −/− fi broblasts. This rescued migration defects (Fig. S1 a, available at http://www.jcb.org/ cgi/content/full/jcb.200511027/DC1). Thus, loss of Rhamm expression results in an inherent migration defect related to a reduced ability of fi broblasts to orient and locomote toward haptotactic cues rapidly.
The invasive properties of Rh −/− versus Wt fi broblasts were compared in 3D collagen type I gels (Fig. 1 B) . Migration of primary Rh −/− dermal fi broblasts into the PDGF/HA/collagen gel plug was reduced by 90% compared with Wt fi broblasts ( Fig. 1 B) , indicating an intrinsic defect in haptotaxis and invasion of Rh −/− fi broblasts. Rh FL expression rescued these defects (Fig. S1 b) .
We previously showed that Rhamm is required for activation of ERK1,2 in culture (Zhang et al., 1998) . Fibroblast migration requires appropriate temporal regulation of signaling pathways such as ERK1,2, which provide cues for promoting and sustaining migration/invasion (Krueger et al., 2001) . To determine whether ERK1,2 activity and/or subcellular targeting is aberrant in Rh −/− fi broblasts and whether the loss of Rhamm is the direct cause of these defects, we quantifi ed serum induction of ERK1,2 activity in Rh −/− versus Rh FLrescued Rh −/− fi broblasts using ELISA, Western blots, and confocal microscopy (Fig. 2) . ELISA analysis showed activation of ERK1,2 in both Rh FL -rescued and Rh −/− fi broblasts (Fig. 2 A) , but activity was less and declined more rapidly in Rh −/− cells (Fig. 2 A) . Western blots confi rmed these results (Fig. 2 B) . Confocal analysis showed that active ERK1,2 are targeted to CD44 is a commonly expressed, integral membrane adhesion and HA receptor that activates motogenic signaling cascades, including ERK1,2 . CD44 coassociates with ERK1,2 via adaptor proteins that bind to its cytoplasmic tail (Bourguignon et al., 2005; Marhaba et al., 2005) . To begin to identify molecular mechanisms that are defi cient in Rh −/− fi broblasts, we fi rst assessed whether Rhamm can coassociate with CD44 and whether both Rhamm and CD44 are required for activation of ERK1,2. CD44s protein was expressed in equivalent amounts in Rhamm-expressing and Rh −/− fi broblasts (Fig. 3 A) . The ability of Rhamm, CD44, and ERK1,2 to associate with each other in Rh FL -rescued fi broblasts was demonstrated in pull-down assays (Fig. 3 B) . Confocal analyses confi rmed coassociation of these proteins in cell processes and CD44-positive perinuclear vesicles (Fig. 3) . Both anti-CD44 and anti-Rhamm antibody signifi cantly reduced the intensity of nuclear phospho-ERK1,2 (Fig. 4 , A and B), raising the possibility that CD44-Rhamm complexes are required for maximal activation of ERK1,2. To test this, the consequences of blocking Rhamm, CD44, and ERK1,2 motogenic functions on fi broblast migration were measured.
Rhamm, CD44, and ERK1,2 are required for motility in response to serum and HA Anti-Rhamm, anti-CD44 antibody, and a mitogen-activated kinase kinase 1 (Mek1) inhibitor (UO126) signifi cantly blocked serum-induced motility of Rh FL -rescued but not Rh −/− fi broblasts (Fig. 4, C and D) , confi rming that Rhamm, CD44, and ERK1,2 activity are required for optimal motility.
Signaling through CD44 and ERK1,2 are required for motility in response to HA (Bourguignon et al., 2005) . We therefore next measured the motility of Rh FL -rescued versus Rh −/− fi broblasts stimulated with HA. To render nontransformed cells sensitive to HA, fi broblasts can be pretreated with PMA; this activates PKC-dependent processes, permitting motogenic responses to HA (Hall et al., 2001) . Compared with PMA treatment alone, a mixture of high molecular weight HA and oligosaccharides signifi cantly promoted random motility of Rh FL -rescued but not Rh −/− fi broblasts (Fig. 4 D) . Motogenic stimulation by HA required cell surface Rhamm, as anti-Rhamm antibodies blocked a response to HA. The inability of HA to increase Rh −/− fi broblast motility was puzzling because these cells express similar levels of CD44s as Wt (Fig. 3 A) . We suspected that the localization of CD44 to the cell surface might be altered in Rh −/− cells, as a reduced number of perinuclear CD44-positive vesicles, which can traffi c to the cell surface (Robertson et al., 2006) , were observed in Rh −/− versus Rh FL -rescued fi broblasts (Fig. 3 A) .
Rhamm promotes surface display of CD44
and codistribution of CD44 with ERK1,2
Adherent Rh
−/− fi broblasts exhibited reduced CD44 surface display compared with Rh FL -rescued fi broblasts (Fig. 5 A) . Both . Anti-Rhamm antibody reduced colocalization of these proteins (Fig. 5 B) . These results suggest a role for cell surface Rhamm in ERK1,2 activation and, consequently, surface display of CD44. We next examined whether activation of ERK1,2 in the absence of Rhamm would have a similar effect. −/− and Wt fi broblasts express similar levels of CD44 proteins (β-actin loading control). One of three experiments is shown. Confocal analysis shows that CD44 (green) occurs mainly in vesicles with phospho-ERK1,2 (red; colocalization shown as white) after Rh FL rescue. CD44 staining is amorphous and not associated with phospho-ERK1,2 in Rh −/− fi broblasts. One of four experiments is shown. (B) Rhamm, CD44, and ERK1,2 form complexes. Recombinant Rhamm-GST proteinSepharose (Rhamm-GST beads) pulls down CD44s, a possible CD44 variant (120 kD), and ERK1,2. One of three experiments is shown. Confocal analysis confi rms that Rhamm (red) and CD44 (green) colocalize (white) in processes of Rh FL -rescued fi broblasts (no Triton X-100) and in vesicles (+Triton X-100). One of three experiments is shown. for Rhamm in these functions. Both cell surface and intracellular Rhamm have been proposed to regulate functions associated with motility and to affect signaling cascades (Turley et al., 2002; Adamia et al., 2005) . The ability of anti-Rhamm antibody to mimic defective motogenic signaling of Rh −/− fi broblasts suggests a role for cell surface Rhamm in these functions but does not exclude an involvement of intracellular Rhamm. Blocking antibodies do not permit a direct assessment of the relative roles of cell surface versus intracellular Rhamm in cell functions. To directly assess the importance of cell surface Rhamm to motogenic signaling, we exposed Rh −/− fi broblasts to recombinant Rhamm linked to Sepharose beads to restrict it to the extracellular compartment.
Rhamm beads signifi cantly stimulated motility of Rh −/− fi broblasts that contacted beads, whereas GST beads had no effect (Fig. 7 A) . Both anti-CD44 and anti-Rhamm antibody (unpublished data) signifi cantly blocked Rhamm bead-stimulated motility. CD44 surface display was dramatically increased in Rh −/− fi broblasts contacting Rhamm beads (Fig. 5 A) . Importantly, fi broblasts defi cient in both Rhamm and CD44 (Rh
) did not increase motility in response to Rhamm beads (Fig. 7 A) . Collectively, these results indicate that cell surface Rhamm is required for CD44 display and motility but that intracellular Rhamm proteins are not required for these functions. Furthermore, these results show that CD44 is required for the motogenic effect of cell surface Rhamm.
To understand the molecular mechanisms by which cell surface Rhamm promotes CD44 surface display and increased motility, we determined whether Rhamm bead-induced motility of Rh −/− fi broblasts requires ERK1,2 activity. Inhibition of Mek1 signifi cantly reduced motility of Rh −/− fi broblasts in contact with Rhamm beads (Fig. 7 A) . Conversely, Rhamm beads signifi cantly stimulated serum-induced ERK1,2 activity and translocation to the nucleus (Fig. 7 B) . ERK1,2 activity was not as high as that of Rh FL -rescued fi broblasts, suggesting a possible role for intracellular Rhamm forms in maintaining maximal activity of these kinases. A role for CD44 in Rhamm bead-promoted ERK1,2 activity was shown by the ability of CD44 antibodies to block Rhamm bead effects and by the lack of Rhamm bead-induced ERK1,2 activity in Rh −/− :CD44 −/− fi broblasts. Because expression of Rhamm and CD44 are increased during excisional skin wound repair (Lovvorn et al., 1998) and fi broblast migration and differentiation are essential components of successful excisional wound repair, we asked whether Rhamm loss alters repair of excisional skin wounds in vivo.
Rhamm expression is required to sustain ERK1,2 activity during granulation tissue formation in vivo
We have shown that Rh −/− fi broblasts exhibit defective activation and subcellular targeting of ERK1,2 via CD44. To prove that Rhamm is indeed a player in the physiological regulation of ERK1,2, their activity was quantifi ed in fi broblasts of Rh −/− versus Wt wound granulation tissue. Wt granulation tissue fi broblasts exhibited strong staining for active ERK1,2 3 d after wounding (Fig. 8) . Staining intensity increased sixfold by day 7 and did not drop signifi cantly until day 13. Rh −/− granulation tissue fi broblasts also exhibited strong activation of ERK1,2 at 3 d after wounding but dropped dramatically by day 7 and remained low at day 13 (Fig. 8 ). These differences in Rh −/− versus Wt ERK1,2 activity were not due to decreases in total ERK1,2 protein levels because immunoblot analyses revealed that Rh −/− and Wt granulation tissue expressed similar amounts of ERK1,2 protein (unpublished data). These results suggest that Rhamm expression is required for sustaining ERK1,2 activity in granulation tissue fi broblasts in vivo as well as in culture. MAPKs have been implicated in processes relevant to wound repair, including contraction, cell migration, and mesenchymal differentiation (Bost et al., 2005; Hornberg et al., 2005) . We therefore next examined the consequences of Rhamm loss and aberrant ERK1,2 signaling on wound repair in vivo.
Loss of Rhamm expression results in abnormal granulation tissue formation and resolution in skin wounds
We fi rst confi rmed that Rhamm expression increases during repair of excisional wounds by analyzing wound Rhamm mRNA during the fi rst 7 d after injury. RT-PCR analysis of uninjured skin confi rmed low Rhamm expression (Fig. S2 a, available at http://www.jcb.org/cgi/content/full/jcb.200511027/DC1). A marked increase in Rhamm mRNA was obvious 1 d after injury, and expression was increased until day 3, when mRNA levels began to drop. By day 7, the mRNA levels were only slightly higher than those observed in uninjured skin. These results indicate that Rhamm is expressed during wound contraction, reepithelialization, and early granulation tissue formation. The consequence of Rhamm loss for the integrity of these early processes was recorded.
Wt and Rh −/− wounds both contracted by 1-3 d after injury, but early contraction of Rh −/− wounds was signifi cantly reduced compared with Wt (Fig. S2 b) . By day 14, Wt and Rh −/− wounds appeared resolved at the macroscopic level (unpublished data). However, analysis of serial tissue sections of wound centers revealed signifi cant reductions in contraction and obvious differences in the dermal structure of Rh −/− wounds at all time points (Fig. S2 c) . 21 d after injury, both the thickness and the cellularity of the remodeling dermis were signifi cantly greater in Rh −/− versus Wt wounds. In addition, the differentiation of structures such as hair shafts and muscle within the wound site was reduced in Rh −/− versus Wt wounds (Fig. S3 b, available at http://www.jcb.org/content/full/jcb.200511027/DC1). A signifi cant decrease in the thickness of Rh −/− versus Wt dermis was also observed before injury (Fig. S3 a) . These observations are consistent with an ERK1,2-regulated defect in Rh −/− wound fi broblast function. We next analyzed the consequences of Rhamm loss on granulation tissue formation/resolution, a process that is dependent on fi broblasts.
A temporal defect in the formation and resolution of granulation tissue was confi rmed in Rh −/− versus Wt wounds (Fig. 9 ). Tenascin-positive granulation tissue was abundant in day 3 Wt wounds and began to decrease by day 7 (Fig. 9 A) . At day 14, Wt wound granulation tissue was largely resolved (Fig. 9 A) . In contrast, the area of tenascin-positive granulation tissue in day 3 and 7 Rh −/− wounds was smaller than Wt. Rh −/− day 14 wounds were still strongly tenascin-positive and highly variable (Fig. 9 B) , as the pattern of staining was "patchy," in contrast to Wt (Fig. 9 A) . An additional difference in Rh −/− wounds was the transient appearance of a thick layer of subcutaneous adipocytes in day 1-3 Rh −/− wounds (Fig. 10 A; unpublished data). These results suggest that a prominent effect of Rhamm loss during wound repair may be a miscuing of signals required for a correct ratio of fi broblasts to adipocytes that arise from progenitor cells, which leads to aberrant regulation of granulation tissue formation and resolution.
Fibroplasia is a particularly prominent feature of granulation tissue in excisional skin wounds. The biological activities of fi broblasts are key factors in the formation of early granulation tissue architecture (Reid et al., 2004) . Robust fibroplasia, as quantifi ed by the density/unit area of granulation tissue fi broblasts, was apparent in Wt wounds on day 3 and was increased by day 7 (Fig. 10 A) . Myofi broblasts, detected by smooth muscle actin staining, appeared in Wt wounds by day 7 (Fig. 10 B) . Fibroplasia was observed in day 3 and 7 Rh −/− granulation tissue but was blunted and accompanied by a signifi cant decrease in myofi broblasts at day 7 (Fig. 10,  A and B) . The presence of abundant wound-edge adipocytes, indicated by the presence of vacuolated cells (Fig. 10 A,  arrow) , was confi rmed by staining with the lipophylic dye BODIPY493/503 (Gocze and Freeman, 1994; unpublished data) . Rh −/− cells explanted from both uninjured skin (day 0) and day 7 wounds expressed less smooth muscle actin and accumulated more lipid than explanted Wt cells (Fig. 10 C) . Thus, deletion of Rhamm results in lower fi broblast density as well as aberrant differentiation in Rh −/− granulation tissue in vivo and in culture.
Discussion
Our study identifi es Rhamm as a fi brogenic factor that is required for temporal and spatial regulation of granulation tissue formation and resolution. An underlying signaling defect associated with Rh −/− wounds is deregulated ERK1,2 activation, which promotes fi broblast migration as well as mesenchymal cell differentiation. This conclusion is supported by the demonstration that Rh −/− fi broblasts are unable to appropriately activate ERK1,2 in culture and exhibit migration defects as measured by several locomotion assays, and that these defects are rescued by expression of mutant active Mek1. Our results further reveal an autocrine mechanism by which cell surface Rhamm promotes motility in culture. This form of Rhamm promotes ERK1,2 activation via an association with CD44, which in turn is required for maintaining cell surface display of CD44. ERK1,2 is acting "downstream" of cell surface Rhamm in this function, as expression of mutant active Mek1 is suffi cient to maintain cell surface CD44, activate ERK1,2, and restore motility in the absence of Rhamm expression. This motogenic mechanism involves formation of cell surface Rhamm-CD44-ERK1,2 complexes and is apparently required for both growth factor-and HA-mediated motility. These fi ndings identify for the fi rst time a mechanism by which Rhamm, a nonintegral membrane protein, can activate intracellular signaling cascades and provide a novel mechanism by which ERK1,2 promotes motility. Furthermore, our results suggest a previously unidentifi ed role for ERK1,2 activation kinetics in excisional skin wound granulation tissue formation/resolution.
Rhamm belongs to a group of proteins that are predominantly intracellular but can be exported to the cell surface via unconventional transport mechanisms that do not involve the export through the Golgi/ER (Nickel, 2005) . We show that cell surface Rhamm is displayed in culture after injury, and our results have begun to clarify functions for cell surface Rhamm versus intracellular Rhamm forms. Although we did not set out to defi ne a role for intracellular Rhamm, indirect evidence suggests that it plays a role in mitotic events, at least in culture, as cell surface Rhamm did not rescue the abnormal mitosis observed during time-lapse analysis of Rh −/− fi broblasts (unpublished data). These results are consistent with evidence for intracellular Rhamm function during progression through G 2 M of the cell cycle (Mohapatra et al., 1996; Maxwell et al., 2003 Maxwell et al., , 2005 and its presence on centrosomes and mitotic spindle microtubules (Maxwell et al., 2003; Evanko et al., 2004) . Nevertheless, our current data do not provide support for an essential role of either intracellular or cell surface Rhamm in mitotic spindle formation and cell cycle regulation during wound repair in dermal fi broblasts in vivo, as judged by the lack of detectable versus Wt wound sites. The slightly disorganized migration of Rh −/− fi broblasts from scratch wound assays on tissue culture plastic is consistent with a possible centrosome defect that could contribute to aberrant migration (Watanabe et al., 2005) and merits further experimentation. A role for Rhamm in collagen contraction has been controversial in culture (Bagli et al., 1999; Travis et al., 2001) . Unexpectedly, therefore, our studies suggest that Rhamm is necessary for recruitment/differentiation of myofi broblasts and contraction of the wound bed. As is increasingly reported and recognized, both of these results emphasize the importance of context and the microenvironment in regulating tissue-specifi c signaling . Thus, data obtained in culture, especially on 2D substrata, need to be confi rmed in vivo.
ERK1 and -2 are closely related MAPK isoforms that are activated by Mek1 or -2 and regulate signaling pathways that control cell motility, invasion, and cytoskeleton remodeling during migration in culture (Yao et al., 2003; Bost et al., 2005) . Our results show that migration defects of Rh −/− fi broblasts result from an inability to sustain and maximally activate ERK1,2 after growth factor stimulation. These results are consistent with our previous evidence that cell surface Rhamm is required for PDGFstimulated ERK1,2 activity in mesenchymal cells and for promoting migration by regulating signaling through upstream activators of ERK1,2, including HA, Src, Ras, and FAK (Hall et al., 1995 (Hall et al., , 1996 Turley et al., 2002) . Others have also documented a role for cell surface Rhamm in activating signaling cascades that regulate motility and that directly or indirectly affect ERK1,2 activation (Lokeshwar and Selzer, 2000; Aitken and Bagli, 2001; Goueffi c et al., 2006) . Although cell surface Rhamm can promote ERK1,2 activity to levels suffi cient to sustain motility in the absence of intracellular forms, levels were lower than in cells expressing both cell surface and intracellular Rhamm (e.g., Rh FL -rescued fi broblasts). Furthermore, although cell surface Rhamm-activated ERK1,2 translocated to the nucleus, activity did not persist here as it did when intracellular Rhamm was also present. These results indirectly implicate intracellular Rhamm forms in aspects of ERK1,2 activation/compartmentalization. These intracellular defi ciencies did not affect the ability of cell surface Rhamm to promote motility during our experimental time frame but could affect other functions associated with ERK1,2 activity, such as invasion and mitosis, neither of which were rescued by cell surface Rhamm alone (unpublished data). The consequences of ERK1,2 signaling on cell differentiation, migration, and proliferation depends on activation kinetics and subcellular compartmentalization (Colucci-D'Amato et al., 2003; Hendriks et al., 2005; Hornberg et al., 2005) . These factors are determined by receptor dimerization and internalization, cross talk with other receptors, association of ERK1,2 with adaptors, and activation of other kinases or phosphatases that modify ERK1,2 activity. Our study raises the possibility that cell surface and intracellular Rhamm may differentially affect the activation levels and subcellular targeting of ERK1,2, which have consequences to motility-and invasion-related gene expression and phosphorylation of intracellular substrates that are involved in cell migration/invasion .
ERK1,2 regulate motility by both transcriptional and posttranslational mechanisms. For example, initiation and early phases of migration during wound repair do not require transcription (Providence and Higgins, 2004) but, rather, involve phosphorylation of predominantly cytoskeleton-associated substrates required for motility, such as myosin Helfman and Pawlak, 2005; Simoes and Fierro, 2005) . Our results also identify a role for ERK1,2 activity in sustaining cell surface display of CD44, an integral membrane protein required for motility in response to growth factors and HA (Toole, 2004) . ERK1,2 promote recycling of clathrin-negative early endosomes back to the cell surface, a pathway associated with recycling of β1 integrins and E-cadherin (Robertson et al., 2006) . A similar ERK1,2-regulated recycling event may be responsible for maintaining CD44 at the cell surface.
We have shown that CD44 and Rhamm have overlapping functions in regulating migration events and that Rhamm can −/− granulation tissue fi broblasts are positive for phospho-ERK1,2 on day 3 after wounding (brown). ERK1,2 activity significantly increases in Wt wound granulation tissue by day 7 and drops to background by day 14. ERK1,2 activity prematurely drops in Rh −/− wound granulation tissue to background at day 7 and remains low at day 14. Mean and SEM; n = 15 images of three serial sections of wounds from fi ve Wt and Rh −/− mice. *, P < 0.05.
compensate for loss of CD44 in aspects of splenocyte migration into arthritic joints, although the reverse may not be true (Nedvetzki et al., 2004) . These and other studies Goueffi c et al., 2006) suggest that Rhamm can promote cell motility independently of CD44. Very likely, in these instances, cell surface Rhamm associates with other adhesion receptors involved in cell motility, and partnering may depend on expression and cell surface display levels of these receptors, which will vary with the nature of disease, cell type, and temporal stage of wound repair. 
Materials and methods
Reagents
Medical-grade HA prepared from bacterial fermentation (a gift from SkyePharma) was free of detectable proteins, DNA, or endotoxins (Filion and Phillips, 2001) . The average molecular mass and polydispersity was 276.7 and 1.221 kD, respectively. HA oligosaccharides (average molecular mass 10 kD; a gift from F. Winnik, University of Montreal, Montreal, Canada) were prepared by partial digestion with testicular hyaluronidase and purifi cation by gel fi ltration. The following primary antibodies were used: ERK1 (immunohistochemistry/Western blot), actin (Western blot), vimentin (immunohistochemistry), α-smooth muscle actin (immunohistochemistry), nonimmune IgG (Santa Cruz Biotechnology, Inc.), Ki67 (immunohistochemistry; DakoCytomation), tenascin (immunohistochemistry; Chemicon), phospho-ERK1,2 (immunohistochemistry/Western blot/immunofl uorescence; Cell Signaling), CD44 (Western blot/immunofl uorescence/blocking; IM7; BD Biosciences), CD44 (blocking; Hermes-3; a gift from D. Naor, The Hebrew University of Jerusalem, Jerusalem, Israel), Rhamm (immunofl uorescence; ProSci), and Rhamm (blocking; Zymed Laboratories). Specifi city of Rhamm and CD44 antibodies were determined using Rh −/− and CD44
−/− cells, respectively. The following secondary antibodies were used: antirabbit Alexa 555 and anti-rat Alexa 433 (Invitrogen), HRP-anti-mouse (Bio-Rad Laboratories), anti-rabbit (BD Biosciences), and anti-rat (Santa Cruz Biotechnology, Inc.). ApopTag peroxidase in situ apoptosis detection kit (Chemicon) was used for quantifi cation of apoptosis, and FACE ERK1/2 ELISA kit (Active Motif) was used to detect phospho-ERK1,2. Other reagents used were as follows: human plasma fi bronectin (BD Biosciences), PDGF (PDGF-BB), and PMA (Sigma-Aldrich); 50 μM PD098059 and 10 μM U0126 (BD Biosciences); collagen (Vitrogen100; Cohesion); Matrigel (BD Biosciences); immunofl uorescence mounting medium with DAPI (Vectashield; Vector Laboratories); Cytoseal (Richard-Allan Scientifi c); and ABC staining system (Santa Cruz Biotechnology, Inc.). All antibodies and reagents were used according to the manufacturer's instructions unless otherwise stated. 
Rh
:CD44
−/− double-knockout mice. Dermal fi broblasts were isolated from newborn skin explants and granulation tissue cells from wound punch explants (cultured dermal side down).
Cell culture, transfection, and antibody blocking Cell culture was done as described previously (Zhang et al., 1998; Tolg et al., 2003) . 25 ng/ml PDGF, 500 ng/ml-1 mg/ml HA, or 10% serum (FCS) were added to 24-h serum-starved, 50% subconfl uent fi broblasts plated on 25 μg/ml fi bronectin-coated dishes (Hall et al., 1996; Zhang et al., 1998) . For HA responsiveness, cells were pretreated with 5 nM PMA (Hall et al., 2001) . For antibody blocking experiments, serumstarved cells were preincubated for 30 min with anti-Rhamm antibody, anti-CD44 antibody, or control IgG (10 μg/ml) before the addition of 10% FCS. Immortalized Rh −/− cells were transfected with murine Rh FL and/or mutant active Mek1 (a gift from N. Ahn, University of Colorado at Boulder, Boulder, CO) using Lipofectamine Plus (Invitrogen) as described previously (Zhang et al., 1998) and were selected in 1-5 mg/ml G418 (Sigma-Aldrich).
Time-lapse analysis
Cells were plated and stimulated with HA or PDGF. For FCS stimulation, fi broblasts were plated onto serum-coated fl asks. Cells were fi lmed as described previously (Zhang et al., 1998; Hall et al., 2001 ).
In vitro wound and invasion assays
Confl uent cell monolayers were starved overnight, scratch wounded (3 mm) with a sized cell scraper, and stimulated with FCS or PDGF for 24-48 h. Monolayers were fi xed (3% paraformaldehyde), stained (0.1% methylene blue), and imaged. For 3D assays, collagen or Matrigel gels containing fi broblasts (5 × 10 5 cells/ml) were prepared with plastic inserts placed in the gel center. After 24-48 h, the inserts were removed and the cell free space was fi lled with collagen containing 25 ng/ml PDGF, 100 μg/ml HA, and 25 ng/ml fi bronectin. Gels were fi xed and analyzed 72 h later.
Western blots
Western blots of CD44, phospho-ERK1,2, and total ERK1,2 proteins were performed as described previously (Schmits et al., 1997; Zhang et al., 1998; Tolg et al., 2003) . Densitometry was performed using Image Quant 5.1 software (Molecular Dynamics).
Immunofl uorescence of cultured cells
Immunofl uorescence of phospho-ERK1,2 was done as described previously (Avizienyte et al., 2004) . Immunofl uorescence of CD44 and Rhamm was done using the same methods with overnight incubation of the primary antibodies at 4°C. Live-cell CD44 immunofl uorescence was done as described previously (Robertson et al., 2006) .
ERK1,2 assays
For quantifi cation of serum or PDGF-induced ERK1,2 activation, cells were plated, serum starved, and stimulated with 10% FCS or PDGF as described. Western blots and immunofl uorescence were done as described. The ERK1,2 ELISA was done according to the manufacturer's instructions.
Recombinant proteins and pull-down assays
Rhamm-GST (72-kD murine isoform) and GST recombinant proteins were prepared as described previously (Mohapatra et al., 1996) . For pull-down assays, recombinant Rhamm-GST or GST beads were incubated with 500 μg of Rh FL -rescued lysate overnight at 4°C. Beads were then washed with cold lysis buffer. Proteins associated with beads were boiled in SDS buffer and were detected by Western blot as described.
Excisional wounds and histology
Wt and Rh
−/− mice were anaesthetized by Halothane inhalation. Two fullthickness 4-mm wounds were placed at the same location on denuded backs of age-matched male mice (9-18 mo), were harvested at the indicated times using an 8-mm metal punch, and were fi xed and paraffi n embedded as described previously (Tolg et al., 2003) . To ensure that serial sections were cut starting at the wound center, samples were cut in half through the wound center before embedding. The fi rst and last sections were stained with Masson's trichrome.
RT-PCR analysis of Rhamm mRNA
Rhamm mRNA was amplifi ed from excised wound tissue, and PCR products were detected as described previously (Tolg et al., 2003) . β-Actin was used as a loading control (Tolg et al., 2003) .
Immunohistochemistry of tissue sections
Immunohistochemistry of paraffi n processed sections was done as described previously (Tolg et al., 2003) . Antigens were retrieved in 10 mM sodium citrate buffer, pH 6, heated to boiling, except for smooth muscle actin staining. Neutral lipids were detected in fi xed cultured cells or frozen wound sections with 25 μg/ml BODIPY 493/503 (Invitrogen; Gocze and Freeman, 1994) .
Image acquisition, image enhancement, image analysis, and statistical analysis
Masson's trichrome, hematoxylin and eosin, vimentin, tenascin, and phospho-ERK1,2 stained tissue section images were taken with air objectives (4×, NA 0.16; 20×, NA 0.7; Olympus) on a microscope (AX70 Provis; Olympus) with a color camera (Cooke SensiCam; CCD Imaging) and Image Pro Plus 4.5.1.2.9 (Media Cybernetics). Phospho-ERK1,2 staining was quantifi ed with Photoshop 6.0 (Adobe). The area of blue (hematoxylin, total number of cells) was quantifi ed. After deletion of the blue pixels, the peroxidase substrate (phospho-ERK1,2) was quantifi ed. Tenascin staining was quantifi ed using Simple PCI (Compix). Images in Fig. 9 A are composites of images taken with the 4× air objective. The colors were enhanced using Photoshop. Scratch wound and surface CD44 immunofl uorescence images were taken with air objectives (4×, NA 0.1, and 20×, NA 0.4, respectively [Nikon] , with Hoffman Modulation Contrast optics) using a microscope (Eclipse TE300; Nikon) with a digital camera (Hamamatsu) and Simple PCI software. In vivo wound images (Fig. S2 a) were taken with a digital camera (Dimage Z3; Minolta) with a 12× zoom. The wound area was quantifi ed using Simple PCI. Confocal images were taken using an oil objective (63×, NA 1.4; Carl Zeiss MicroImaging, Inc.) with a confocal microscope (510 LSM Meta; Carl Zeiss MicroImaging, Inc.) using LSM 5 software (Carl Zeiss MicroImaging, Inc.) . Fluorescence intensity of images was measured using LSM 5 software. Colocalization was identifi ed and quantifi ed using ImageJ software (http://rsb.info.nih.gov/ij/). Cell surface CD44 images were deconvolved using Simple PCI's nearest-neighbor deconvolution. All images were acquired at room temperature. Unless otherwise indicated, comparisons between samples were assessed for statistical signifi cance using a t test; P < 0.05 was considered signifi cant, and significant differences between values are marked with asterisks. Fig. S1 shows that transfection of Rh FL into Rh −/− fi broblasts rescues defective migration in scratch wounds and invasion in collagen gel assays. Fig.  S2 shows that Rhamm mRNA expression is transiently increased after excisional skin wounding between days 1 and 7. Photographs of wounds show that Rh −/− wounds contract more slowly than Wt. Tissue sections through excisional skin wounds confi rm that loss of Rhamm results in signifi cantly reduced wound contraction relative to Wt. Fig. S3 shows that the dermal structure of uninjured and repaired Rh −/− skin is aberrant compared with Wt. This includes alterations in dermal thickness and in differentiation of dermal cell types. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200511027/DC1.
Online supplemental material
